About
Technology
Issues
FAQ
Search
Profile
Top Authors
Prolific Authors
Top Journals
Main Disciplines
Main Topics
Most Cited Articles
Scientometrics
Avg Impact Factor
★★
Articles
★★★
Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Schools
›
Division of Hematology-Oncology
›
top-articles
Division of Hematology-Oncology
169
(top 1%)
papers
13.2K
(top 1%)
citations
55
(top 1%)
h
-index
113
(top 1%)
g
-index
177
all documents
13.9K
doc citations
2.6K
citing journals
Top Articles
#
Title
Journal
Year
Citations
1
Phase II, Randomized Trial Comparing Bevacizumab Plus Fluorouracil (FU)/Leucovorin (LV) With FU/LV Alone in Patients With Metastatic Colorectal Cancer
Journal of Clinical Oncology
2003
1,618
2
Activity of the Dual Kinase Inhibitor Lapatinib (GW572016) against HER-2-Overexpressing and Trastuzumab-Treated Breast Cancer Cells
Cancer Research
2006
846
3
Anti-PD-1 therapy in patients with advanced melanoma and preexisting autoimmune disorders or major toxicity with ipilimumab
Annals of Oncology
2017
641
4
Assessment of Methods for Tissue-Based Detection of the HER-2/neu Alteration in Human Breast Cancer: A Direct Comparison of Fluorescence In Situ Hybridization and Immunohistochemistry
Journal of Clinical Oncology
2000
627
5
Zoledronic acid reduces skeletal-related events in patients with osteolytic metastases
Cancer
2001
494
6
PD-1 Blockade Expands Intratumoral Memory T Cells
Cancer Immunology Research
2016
321
7
The effect of HER-2/neu overexpression on chemotherapeutic drug sensitivity in human breast and ovarian cancer cells
Oncogene
1997
317
8
Development of Protacs to Target Cancer-promoting Proteins for Ubiquitination and Degradation
Molecular and Cellular Proteomics
2003
302
9
sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance
Nature
2016
290
10
Current Developments in Cancer Vaccines and Cellular Immunotherapy
Journal of Clinical Oncology
2003
287
11
Activated Phosphoinositide 3-Kinase/AKT Signaling Confers Resistance to Trastuzumab but not Lapatinib
Molecular Cancer Therapeutics
2010
283
12
An Effective Immuno-PET Imaging Method to Monitor CD8-Dependent Responses to Immunotherapy
Cancer Research
2016
265
13
PIAS1 selectively inhibits interferon-inducible genes and is important in innate immunity
Nature Immunology
2004
232
14
Releasing the Brakes on Cancer Immunotherapy
New England Journal of Medicine
2015
207
15
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of non-small cell lung cancer (NSCLC)
2018
188
16
Regulation of cytokine signaling pathways by PIAS proteins
Cell Research
2006
182
17
PARP inhibitors for BRCA1/2-mutated and sporadic ovarian cancer: current practice and future directions
British Journal of Cancer
2016
163
18
Current and future role of neoadjuvant therapy for breast cancer
Breast
2014
162
19
Role of the Aggresome Pathway in Cancer: Targeting Histone Deacetylase 6–Dependent Protein Degradation
Cancer Research
2008
155
20
Social Stress Enhances Sympathetic Innervation of Primate Lymph Nodes: Mechanisms and Implications for Viral Pathogenesis
Journal of Neuroscience
2007
146
21
Proinflammatory Stimuli Induce IKKα-Mediated Phosphorylation of PIAS1 to Restrict Inflammation and Immunity
Cell
2007
145
22
The Oncogenic BRAF Kinase Inhibitor PLX4032/RG7204 Does Not Affect the Viability or Function of Human Lymphocytes across a Wide Range of Concentrations
Clinical Cancer Research
2010
142
23
HER-2/neu Gene Amplification and Response to Paclitaxel in Patients With Metastatic Breast Cancer
Journal of the National Cancer Institute
2004
139
24
Negative Regulation of NF-κB Signaling by PIAS1
Molecular and Cellular Biology
2005
138
25
A highly efficient short hairpin RNA potently down-regulates CCR5 expression in systemic lymphoid organs in the hu-BLT mouse model
Blood
2010
132
26
Neratinib overcomes trastuzumab resistance in HER2 amplified breast cancer
Oncotarget
2013
132
27
Pomegranate extract inhibits androgen-independent prostate cancer growth through a nuclear factor-κB-dependent mechanism
Molecular Cancer Therapeutics
2008
129
28
Venetoclax for patients with chronic lymphocytic leukemia who progressed during or after idelalisib therapy
Blood
2018
122
29
Different Patterns of Akt and ERK Feedback Activation in Response to Rapamycin, Active-Site mTOR Inhibitors and Metformin in Pancreatic Cancer Cells
PLoS ONE
2013
118
30
Preoperative β-Blockade with Propranolol Reduces Biomarkers of Metastasis in Breast Cancer: A Phase II Randomized Trial
Clinical Cancer Research
2020
113
31
Molecular properties of CD133+ glioblastoma stem cells derived from treatment-refractory recurrent brain tumors
Journal of Neuro-Oncology
2009
111
32
Phase II Multicenter Study of Arsenic Trioxide in Patients With Myelodysplastic Syndromes
Journal of Clinical Oncology
2006
106
33
Placenta and appetite genes GDF15 and IGFBP7 are associated with hyperemesis gravidarum
Nature Communications
2018
106
34
Acute kidney injury in patients treated with immune checkpoint inhibitors
2021
103
35
PIASx Is a Transcriptional Co-repressor of Signal Transducer and Activator of Transcription 4
Journal of Biological Chemistry
2003
101
36
Regulation of protein tyrosine phosphatase 1B by sumoylation
Nature Cell Biology
2007
100
37
Antitumor activity from antigen-specific CD8 T cells generated in vivo from genetically engineered human hematopoietic stem cells
Proceedings of the National Academy of Sciences of the United States of America
2011
97
38
Therapeutic Potential of the Poly(ADP-ribose) Polymerase Inhibitor Rucaparib for the Treatment of Sporadic Human Ovarian Cancer
Molecular Cancer Therapeutics
2013
93
39
Effective molecular targeting of CDK4/6 and IGF-1R in a rare
FUS-ERG
fusion
CDKN2A
-deletion doxorubicin-resistant Ewing's sarcoma patient-derived orthotopic xenograft (PDOX) nude-mouse model
Oncotarget
2016
91
40
Clinical outcomes of patients with advanced gastrointestinal stromal tumors: Safety and efficacy in a worldwide treatment‐use trial of sunitinib
Cancer
2015
89
41
Periostin promotes ovarian cancer angiogenesis and metastasis
Gynecologic Oncology
2010
88
42
Activity of the multikinase inhibitor dasatinib against ovarian cancer cells
British Journal of Cancer
2009
81
43
Cocaine and -1 receptors modulate HIV infection, chemokine receptors, and the HPA axis in the huPBL-SCID model
Journal of Leukocyte Biology
2005
75
44
New Challenges in Endpoints for Drug Development in Advanced Melanoma
Clinical Cancer Research
2012
72
45
Advances in Targeted Therapies for Triple-Negative Breast Cancer
Drugs
2019
71
46
Activity of the Fibroblast Growth Factor Receptor Inhibitors Dovitinib (TKI258) and NVP-BGJ398 in Human Endometrial Cancer Cells
Molecular Cancer Therapeutics
2013
69
47
A Pilot Trial of the Combination of Transgenic NY-ESO-1–reactive Adoptive Cellular Therapy with Dendritic Cell Vaccination with or without Ipilimumab
Clinical Cancer Research
2019
69
48
Functional and Oncological Outcomes of Partial Nephrectomy of Solitary Kidneys
Journal of Urology
2009
67
49
Combination treatment with recombinant methioninase enables temozolomide to arrest a BRAF V600E melanoma in a patient-derived orthotopic xenograft (PDOX) mouse model
Oncotarget
2017
67
50
Monocyte Function in Man
Journal of Immunology
1977
66
site/software ©
exaly
; All materials licenced under
CC by-SA
.